IRVINE, Calif., Oct. 9, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced the FDA 510(k) clearance and market release of Masimo's new uSpO 2 ™ universal pulse oximetry cable for use with GE ...
More than a decade into their partnership, Masimo and GE HealthCare are still finding new ways to combine their respective patient monitoring technologies. In the latest expansion of their ...
CHICAGO & IRVINE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo Signal Extraction Technology® (SET®) pulse ...
GE Healthcare and Masimo have announced a joint agreement to integrate Masimo’s Signal Extraction Technology (SET) pulse oximetry into GE’s Portrait Mobile wireless and wearable patient monitoring ...
Masimo's SET pulse oximetry technology lessens measurement errors found in other types of pulse oximeters, and offers greater accuracy during patient low perfusion, an important consideration when ...
Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...
Masimo’s revolutionary SET ® pulse oximetry has been shown in more than 100 independent and objective studies to outperform other pulse oximetry technologies – even before the revisions that achieved ...
About a year after beginning its full market launch, Masimo’s W1 smartwatch can now be used as a medical device in the U.S. The wearable device has earned FDA clearance for its medical applications, ...
Masimo's uSpO 2 ™ (pictured) is a "Board-in-Cable" external pulse oximetry solution that provides a simple way to add Masimo SET ® pulse oximetry for devices that are not designed to have SpO 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results